Capri Global insurance push targets ₹20cr fee in FY25

What Capri Global announced

Capri Global Capital Limited (CGCL), an RBI-registered NBFC-ICC incorporated in November 1994, said it plans to develop an insurance platform to maximise the composite Corporate Agency licence it received from the Insurance Regulatory and Development Authority of India (IRDAI). The licence, received in December 2023, allows CGCL to distribute life, general, and health insurance products. The company positioned the move as a diversification of offerings and a way to strengthen fee income. It also said it intends to use technology to change how insurance products and services are delivered to customers. The platform is planned across multiple channels including the company’s website, app, and call centres. CGCL linked the initiative to IRDAI’s broader objective of improving insurance penetration, referencing the “Insuring India by 2047” mission. The announcement drew a sharp reaction in the stock during the January 16, 2024 session.

IRDAI composite corporate agency licence: what it enables

The composite corporate agency licence permits the distribution of life, general, and health insurance products. CGCL said it will offer tailored insurance solutions to its borrower clients, giving them options to cover life and non-life risks. Management highlighted the opportunity to cross-sell insurance using CGCL’s borrower relationships. The company operates across retail lending segments including MSME, Affordable Housing, and Gold Loans, and it largely lends to self-employed non-professional borrowers. This customer profile, combined with branch-led distribution, is central to the cross-sell strategy described by the company. CGCL also said the licence can help broaden the NBFC’s product suite beyond lending, potentially increasing the share of non-interest revenue. The company’s commentary across releases consistently framed insurance distribution as a fee-income lever rather than a balance-sheet-heavy business. CGCL expects the insurance activity to contribute to earnings through net fee income, with FY25 being the key milestone cited.

How the proposed insurance platform is expected to work

CGCL said the insurance offering will be accessible through its website, app, and call centres, indicating a mix of digital and assisted distribution. A customer-friendly payment policy is planned, with premium payments supported through digital wallets, credit cards, debit cards, and net banking. On the operations side, the company said it plans to use data analytics, artificial intelligence, and blockchain to deliver insurance solutions. The stated intent is to automate claims processing and customer support services to reduce operating costs while improving customer satisfaction. CGCL described the goal of the insurtech platform as creating an ecosystem of insurers that can offer affordable, customer-friendly coverage options. This framing suggests the platform is meant to aggregate and distribute products rather than manufacture them. The company has not disclosed product-level details in the provided information, but it has emphasised process automation, multi-channel distribution, and digital payments as core design elements. The plan was presented as an extension of the corporate agency licence rather than a separate regulated insurance entity.

Distribution strength: branches, clients, and cross-sell base

CGCL said it aims to leverage its branch network in North and West India to cross-sell insurance products. One release stated the company had 917 branches across 14 states and Union Territories as of September 2023, supported by over 10,150 employees. Management also highlighted growth in its customer relationships. CGCL’s MD and CEO Rajesh Sharma said the active client base increased 5 times year-on-year to 270,000 as of September 2023. In H1 FY24, the company said it disbursed total loans of ₹6,200 crore and added 107,000 live clients. It also said that, on behalf of partner banks, it originated car loans of ₹4,400 crore, translating into 39,000 new clients. The company’s stated strategy is to use this expanding client base as a captive audience to improve insurance penetration. The operating logic is straightforward: lending touchpoints and branch presence can be used to distribute protection products at the point of customer need.

Key financial and operating metrics cited

CGCL disclosed several operating indicators that set the context for the insurance initiative. Consolidated assets under management (AUM) stood at ₹12,360 crore as of September 2023, up 59% year-on-year. Non-interest income for the half-year ended September 2023 was ₹160.7 crore, up 58% year-on-year. The company expects to generate net fee income of ₹20 crore from insurance cross-sell in FY25. Another update also referred to expected net insurance income of about ₹20 crore in FY 2024-25, alongside an expected increase in variable costs of about ₹2-3 crore annually. These figures indicate the company is guiding to a relatively modest but measurable fee stream versus its broader lending book, with costs that it has explicitly acknowledged. CGCL also described insurance distribution as additive to fee income, aligning with its objective of diversifying revenues. While the disclosures do not provide segment profitability, they outline the scale of the lending franchise and the incremental financial contribution management is targeting from insurance.

Stock reaction on January 16, 2024

Capri Global Capital’s share price rose sharply on January 16, 2024, following updates around the insurance platform plan and the IRDAI licence. At around 1 pm, the stock was quoted at ₹913.25, up 12.17% from the previous close of ₹814.20 on the BSE. Another update cited 11:55 a.m. levels of ₹915.75, up 12.61% from a prior close of ₹813.20, with market capitalisation at about ₹18,910 crore. The stock also traded as high as ₹916.85 during the session, with some reports noting gains of up to about 15% intraday. On the day, the stock opened at ₹905 and moved between ₹875.10 and ₹937.95. The 52-week high and low were cited as ₹939.95 and ₹565.85, respectively. Market capitalisation figures in the updates ranged around ₹18,834.41 crore to ₹19,111.80 crore depending on the timestamp. The price action suggests the market quickly priced in the potential for incremental fee income and product diversification.

Data table: licence, platform plan, and key numbers

Market impact: why investors tracked this closely

The immediate market focus was on diversification and fee income potential. CGCL explicitly said the licence and platform plan should strengthen fee income, and it backed that with an FY25 net fee income target of ₹20 crore from insurance cross-sell. Investors also appeared to value the company’s distribution scale, including its branch network and the reported 270,000 active clients, as it underpins cross-sell feasibility. The use of automation in claims processing and customer support was positioned as a cost-control lever, which matters when new businesses can otherwise bring higher servicing costs. The stock’s sharp move also reflected that the news is incremental to the company’s existing lending franchise rather than a pivot away from it. Separately, the company cited a market cap near ₹18,834-19,112 crore during the session, making the move meaningful in absolute value terms. Reports also noted the stock had risen nearly 20% in the prior month, outperforming the Nifty’s 3% gain in the same period, indicating momentum was already present. The announcement added a clear narrative around new fee streams, which markets often track closely for NBFCs.

Analysis: what the platform plan signals about CGCL’s strategy

CGCL’s disclosures indicate a strategy to use lending relationships to sell protection products, supported by branch presence and digital channels. The platform narrative is built around operational efficiency, with repeated references to automating claims processing and customer support. Importantly, the company did not present insurance distribution as a capital-intensive expansion, but as a fee-income line enabled by a regulator-issued licence. The disclosed targets and costs provide a rough framework: ₹20 crore in net fee income in FY25, and an expected annual variable cost increase of ₹2-3 crore linked to the insurance business. The choice to emphasise analytics, AI, and blockchain also signals that CGCL wants a technology-led distribution and servicing layer, although the disclosures do not provide timelines for rollout stages. The initiative also sits alongside CGCL’s existing lending products for MSMEs, affordable housing, and gold loans, suggesting the insurance effort is intended to deepen customer engagement rather than broaden credit risk. The company’s reference to “Insuring India by 2047” places the plan within a broader regulatory and industry push toward higher coverage levels. For investors, the key takeaway from the reported information is the effort to increase non-interest revenue through cross-sell, supported by a growing client base.

What to watch next

CGCL said it expects to generate ₹20 crore in net fee income from insurance cross-sell in FY25, making execution progress and early traction important signposts. The company has also indicated it will rely on multiple channels, including app and call centres, so updates on platform launch and adoption would matter. Another near-term event flagged in the information provided is the company’s December quarter results, scheduled for January 27. Over time, investors are likely to track whether the insurance distribution effort materially lifts non-interest income beyond the ₹160.7 crore reported for the half-year ended September 2023. The company’s disclosures also set expectations around incremental variable costs of ₹2-3 crore annually, which creates a benchmark for monitoring operating leverage. With AUM at ₹12,360 crore as of September 2023, CGCL’s scale provides context for how large or small the insurance contribution is in the overall financial mix. Future announcements around insurer partnerships, product breadth, and servicing metrics would further clarify how the ecosystem approach is being implemented. For now, the confirmed milestones are the December 2023 IRDAI licence and the January 2024 plan to build a supporting insurtech platform.